Primary Record
anisomycin
- In stock
- 4,219 g
- Purity
- 99.6 %
- CAS
- 22862-76-6
Compound Identifiers & Properties
- CAS
- 22862-76-6
- PubChem CID
- 253602
- SMILES
- CC(=O)O[C@@H]1[C@H](CN[C@@H]1CC2=CC=C(C=C2)OC)O
- Canonical SMILES
- COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1
Names & Synonyms
- anisomycin
- Flagecidin
- (-)-Anisomycin
- 22862-76-6
- Anisomycin?
- Upjohn 204t3
- (-) Anisomycin
- Antibiotic PA-106
- Anisomycin =97%
- 6C74YM2NGI
- Anisomycin hydrochloride
- Spectrum_001534
- ANISOMYCIN [MI]
- ANISOMYCIN 25MG
- UNII-6C74YM2NGI
- Flagecidin;Wuningmeisu C
- AC1L5OGT
- Prestwick3_000412
- RefChem:558141
- Spectrum2_000632
- Spectrum4_000748
- Spectrum5_001495
- GlyTouCan:G83616OI
- TCMDC-125504
- ANISOMYCIN 100MG
- DTXSID5040966
- MFCD00077650
- NSC-76712
- NSC76712
- AC1Q1L8A
- MLS001066392
- YKJYKKNCCRKFSL-RDBSUJKOSA-N
- ANISOMYCIN, (-)-
- CBiol_002064
- Anisomycin from Streptomyces griseolus
- BSPBio_000364
- BSPBio_001436
- KBioGR_001076
- KBioSS_002014
- ZINC954
- C14H19NO4
- DivK1c_000855
- SPECTRUM1503906
- Anisomycin, Streptomyces griseolus
- CHEBI:338412
- SPBio_000624
- 6CQU2V295F
- BPBio1_000402
- CHEMBL423192
- cid_253602
- SCHEMBL2270183
- (2R,3S,4S)-4-hydroxy-2-(4-methoxybenzyl)pyrrolidin-3-yl acetate
- Anisomycin,streptomyces griseolus
- DTXCID3020966
- BDBM63919
- EINECS 245-269-7
- ERK5-6N18
- HMS502K17
- KBio1_000855
- KBio2_002014
- KBio2_004582
- KBio2_007150
- NINDS_000855
- NSC 76712
- Bio1_000350
- Bio1_000839
- Bio1_001328
- GLXC-07963
- HMS1922K06
- HMS2096C06
- HMS2231E05
- HMS3267L11
- HMS3414L17
- HMS3678L15
- NSC 147340
- EBD11190
- G83616OI
- BRN 0020705
- 2-(p-Methoxybenzyl)-3,4-pyrrolidinediol 3-acetate
- AR-1L5885
- BBF-00692
- C14-H19-N-O4
- CCG-39185
- CID253602
- HB2239
- NSC147340
- (2R,3S,4S)-2-(p-Methoxybenzyl)-3,4-pyrrolidinediol 3-acetate
- SMR000471874
- AKOS015916532
- AA10006
- AI3-50846
- CID:253602
- CS-4981
- DB07374
- SDCCGMLS-0066810.P001
- 6185-RBK-10
- IDI1_000855
- KS-0000001J
- QTL1_000009
- NCGC00025097-02
- NCGC00025097-03
- NCGC00025097-04
- 2-p-Methoxyphenylmethyl-3-acetoxy-4-hydroxypyrrolidine
- AC-35125
- AS-44380
- HY-18982
- J60.442I
- NCI60_041689
- SID:53789238
- SY057421
- [(2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-3-yl] acetate
- 2-(p-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate
- 3,4-Pyrrolidinediol, 2-[(4-methoxyphenyl)methyl]-, 3-acetate,(2R,3S,4S)-
- A2613
- AB00513833
- B6674
- FT-0622405
- 5-21-05-00523 (Beilstein Handbook Reference)
- A11271
- A11772
- C11281
- (2R,3S,4S)-2-(p-Methoxyphenylmethyl)-3-acetoxy-4-hydroxypyrrolidine
- (2R,3S,4S)-2-((4-Methoxyphenyl)methyl)-3,4-pyrrolidinediol 3-acetate
- 1,4,5-Trideoxy-1,4-imino-5-(p-methoxyphenyl)-D-xylo-pentitol 3-acetate
- A927918
- D000841
- Q378498
- SR-01000597397
- 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R,3S,4S)-
- SR-01000597397-1
- SR-01000597397-3
- (2R,3S,4S)-2-[(4-Methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-acetate
- BRD-K91370081-001-04-6
- BRD-K91370081-001-17-8
- BRD-K91370081-001-25-1
- I14-51828
- (2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-3-yl acetate
- 3, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)-
- 3,4-Pyrrolidinediol, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, (2R,3S,4S)-
- 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2alpha,3alpha,4beta))-
- 3,4-Pyrrolidinediol, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)-
- Anisomycin, 99%, from Streptomyces griseolus - 10MG 10mg
- Anisomycin from Streptomyces griseolus, >=98% (HPLC), solid
- (2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol 3-Acetate
- (2R,3S,4S)-4-hydroxy-2-(4-methoxybenzyl)pyrrolidin-3-ylacetate
- (2R)-2alpha-(4-Methoxybenzyl)pyrrolidine-3alpha,4beta-diol 3-acetate
- 1,4-Imino-5-(4-methoxyphenyl)1,4,5-trideoxy-D-xylo-pentitol 3-acetate
- 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2-alpha,3-alpha,4-beta))-
- acetic acid [(2R,3S,4S)-4-hydroxy-2-p-anisyl-pyrrolidin-3-yl] ester
- ANM
- Rel-(2R,3S,4S)-4-hydroxy-2-(4-methoxybenzyl)pyrrolidin-3-yl acetate
- ((2R,3S,4S)-4-hydroxy-2-((4-methoxyphenyl)methyl)pyrrolidin-3-yl) acetate
- [(2R,3S,4S)-2-[(4-methoxyphenyl)methyl]-4-oxidanyl-pyrrolidin-3-yl] ethanoate
- [2R-(2alpha,3alpha,4beta)]-2-[(4-methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-acetate
- 3, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, [2S-(2.alpha.,3.alpha.,4.beta.)]-
- Acetic acid (2R)-4beta-hydroxy-2-(4-methoxybenzyl)pyrrolidin-3alpha-yl ester
- acetic acid [(2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]-3-pyrrolidinyl] ester
- D-xylo-Pentitol, 1,4,5-trideoxy-1,4-imino-5-(4-methoxyphenyl)-, 3-acetate
- (2R,3S,4S)-2-[(4-Methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-Acetate; (-)-Anisomycin(2R,3S,4S)-2-(p-Methoxybenzyl)-3,4-pyrrolidinediol 3-Acetate;(2R,3S,4S)-2-(p-Methoxyphenylmethyl)-3-acetoxy-4-hydroxypyrrolidine; (-)-Anisomycin; Flagecidin; NSC 76712; Wuningmeisu C
- (5Z)-7-Oxozeaenol,(3S,5Z,8S,9S,11E)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-14-methoxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
- [[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]carbamicacidethylester
- 11023-48-6
- 21497-40-5
- 245-269-7
- 25940-57-2
- 3,4-Pyrrolidinediol, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, [2R-(2.alpha.,3.alpha.,4.beta.)]-
- 66018-38-0
- ANI